Fig. 2: Statistics of datasets in CellResDB.
From: Deciphering cancer therapy resistance via patient-level single-cell transcriptomics with CellResDB

a Schematic displaying the distribution of resources in CellResDB. The lollipop icon shows treatment response, with blue indicating response and red indicating non-response. Numbers represent treatment types: chemotherapy, hormone therapy, immunotherapy, and targeted therapy. Notably, ‘B-ALL’ is categorized under ‘ALL’, ‘FLT3-ITD AML’ is under ‘AML’, ‘IgG lambda MM’ under ‘MM’, and ‘CM’ under ‘MEL’. b Sunburst plot showing the distribution of 72 datasets across tissues (n = 12) and diseases (n = 21). The outer ring represents tissue types, and the inner ring displays diseases, colored by category. c Bar chart showing the frequency of datasets by treatment type, with chemotherapy, hormone therapy, immunotherapy, and targeted therapy represented. The lollipop plot below emphasizes different treatments across datasets (n = 72), displaying single lollipops for individual therapies and connected lollipops for combined therapies. d Bar chart showing the frequency of drugs (n = 54) used across the datasets. The y-axis represents the drug symbol, and the x-axis indicates the number of datasets in which each drug is included. e Frequency distribution of datasets (n = 72) by the number of cell types. The x-axis shows the interval of the cell type number in each dataset, while the y-axis represents the number of datasets for each range. f Bar chart showing the frequency distribution of datasets (n = 72) by the number of cells, where the x-axis represents the interval of the cell numbers in each dataset, displayed in powers of 10, and the y-axis indicates the number of datasets corresponding to each range. g Bar plot showing the total number of samples collected before (Pre, n = 631) and after (Post, n = 760) treatment across all datasets. B-ALL: B-cell acute lymphoblastic leukemia; ALL: acute lymphoblastic leukemia; FLT3-ITD AML: Primary FLT3-ITD-mutated acute myeloid leukemia; AML: acute myeloid leukemia; IgG lambda MM: immunoglobulin G lambda multiple myeloma; MM: multiple myeloma; CM: cutaneous melanoma; MEL: melanoma. The organ illustrations were created using the Generic Diagramming Platform available at https://biogdp.com/47.